I was impressed by the microphotographs presented at the AGM...

I was impressed by the microphotographs presented at the AGM showing the results of AOD9604 and hyaluronic acid combination treatment in the rabbit model. I think this was the research done in Korea.

Subsequently a friend I spoke with about this possible development gave me this link to a doctor's website. Doctor Allan Dunn has been successfully treating osteoarthritis for years with off-label recombinant human growth hormone injected directly onto the affected joint. Dr. Dunn calls this treatment "IAGH" for Intra Articular Growth Hormone.

This gives me further reason to believe that the company is actually on to something potentially huge with this application for AOD9604 which may have a similar mode of action, and perhaps could be approved by the FDA for this indication specifically.

From the website:

"The IAGH process rejuvenates adult blood vessels in your joint to form fetal vessels. These fetal vessels produce your own (Autologous) stem cells which then form cartilage cells (Chondrocytes). These new cartilage cells produce a new cartilage surface in your joint. This process has been published in a peer reviewed journal: "Morphoangiogenesis - a Unique Action of Growth Hormone", Allan R. Dunn, M.D., Microvascular Research Vol. 63 pages 295 - 303, 2002."

Link: http://www.iagh.com/